Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)
Phase 3
Completed
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT00092586
- Lead Sponsor
- Organon and Co
- Brief Summary
The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol.
- Detailed Description
The duration of treatment is 6 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2904
Inclusion Criteria
- High cholesterol levels that are identified by specific laboratory values
Exclusion Criteria
- Active liver disease
- Any condition or situation which would interfere with participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percent change in LDL-C
- Secondary Outcome Measures
Name Time Method Percentage of patients reaching NCEP ATP III target LDL-C levels